MicroRNAs may drive the development of leukemia

from The Scientist
Volume 25 | Issue 1 | Page 47
Date: 2011-01-01
By Katherine Hyde and Paul Liu

Interfering with Cancer

Acute myeloid leukemia (AML) is a cancer of the blood-cell producing bone marrow with several subtypes, and is usually fatal within months, or even weeks, if left untreated. It is now becoming clear, however, that dysregulation of microRNAs (miRs) is not simply a side effect of the cancer; rather, it could play a mechanistic role in the development of leukemia.

Read more: Interfering with Cancer – The Scientist – Magazine of the Life Sciences http://www.the-scientist.com/article/display/57885/#ixzz19nNV34TD

Incoming search terms for this article:

• development of leukemia

Related posts:

1. MicroRNA miR-125b Causes Leukemia
2. MicroRNA Clusters Implicated in Chronic Lymphocytic Leukemia
3. Outsourcing your RNA
4. Patterns of microRNA Expression in Non-Human Primate Cells Correlate with Neoplastic Development In Vitro
5. 8th Annual microRNA In Human Health & Development Conference

Tagged as: AML, leukemia, microrna, mirna